デフォルト表紙
市場調査レポート
商品コード
1386215

ライブセルイメージングの世界市場:動向、予測、競合分析(~2030年)

Live Cell Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ライブセルイメージングの世界市場:動向、予測、競合分析(~2030年)
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ライブセルイメージングの動向と予測

世界のライブセルイメージングの市場規模は、2024~2030年にかけてCAGR 11.1%で成長し、2030年までに約58億7,000万米ドルに達すると予測されています。この市場の主な促進要因は、創薬におけるハイコンテントスクリーニング技術の採用の増加、がん罹患率の増加、細胞ベースの研究に対する政府資金の増加です。世界のライブセルイメージング市場の将来は、細胞生物学、幹細胞、発生生物学、創薬市場にビジネスチャンスがありそうです。

ライブセルイメージング市場の洞察

Lucintelは、細胞や組織機能の基本的な性質に関する重要な洞察を提供するのに役立つことから、予測期間中、機器が最大セグメントであり続けると予測しています。

この市場の中では、幹細胞は、自己複製と多様な細胞型への分化というユニークな能力により、細胞置換療法や組織工学療法への採用が増加しているため、最大セグメントであり続けると思われます。

アジア太平洋は、ヘルスケアインフラと研究開発活動への投資の増加、精密医療と創薬用途におけるこれらのイメージング技術の採用増加により、予測期間中に最も高い成長が見込まれています。

市場規模・推計:ライブセルイメージングの市場規模を金額(10億米ドル)で推計

動向と予測分析:各種セグメント別、地域別の市場動向(2018~2023年)と予測(2024~2030年)

セグメンテーション分析:ライブセルイメージング市場を製品・サービス別、技術別、用途別、最終用途別、地域別など様々なセグメント別に金額(10億米ドル)で推定

地域別分析:ライブセルイメージング市場の北米、欧州、アジア太平洋、その他の地域別内訳

成長機会:ライブセルイメージング市場の製品・サービス、技術、用途、最終用途、地域別の成長機会分析

戦略分析:ライブセルイメージング市場のM&A、新製品開発、競合情勢など

ポーターのファイブフォースモデルに基づく業界の競合強度分析

本レポートは以下の11の主要な質問に回答しています:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界のライブセルイメージング市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析:2018~2030年

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界のライブセルイメージング市場の動向(2018~2023年)と予測(2024~2030年)
  • 世界のライブセルイメージング市場:製品・サービス別
    • 機器
    • 消耗品
    • ソフトウェア
    • サービス
    • その他
  • 世界のライブセルイメージング市場:技術別
    • Time-Lapse Microscopy
    • Fluorescence Resonance Energy Transfer
    • Fluorescence Recovery After Photobleaching
    • High Content Screening
    • その他
  • 世界のライブセルイメージング市場:用途別
    • 細胞生物学
    • 幹細胞
    • 発生生物学
    • 創薬
    • その他
  • 世界のライブセルイメージング市場:最終用途別
    • 製薬・バイオテクノロジー企業
    • 学術調査機関
    • 受託調査機関
    • その他

第4章 市場動向と予測分析:地域別(2018~2030年)

  • 世界のライブセルイメージング市場:地域別
  • 北米のライブセルイメージング市場
  • 欧州のライブセルイメージング市場
  • アジア太平洋のライブセルイメージング市場
  • その他の地域のライブセルイメージング市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品・サービス別の世界のライブセルイメージング市場の成長機会
    • 技術別の世界のライブセルイメージング市場の成長機会
    • 用途別の世界のライブセルイメージング市場の成長機会
    • 最終用途別の世界のライブセルイメージング市場の成長機会
    • 地域別の世界のライブセルイメージング市場の成長機会
  • 世界のライブセルイメージング市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のライブセルイメージング市場の能力拡大
    • 世界のライブセルイメージング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies
目次

Live Cell Imaging Trends and Forecast

The future of the global live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets. The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030 with a CAGR of 11.1% from 2024 to 2030. The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

A more than 150-page report is developed to help in your business decisions.

Live Cell Imaging by Segment

The study includes a forecast for the global live cell imaging by product & service, technology, application, end use, and region.

Live Cell Imaging Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Software
  • Services
  • Others

Live Cell Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Time-Lapse Microscopy
  • Fluorescence Resonance Energy Transfer
  • Fluorescence Recovery After Photobleaching
  • High Content Screening
  • Others

Live Cell Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery
  • Others

Live Cell Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organisations
  • Others

Live Cell Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Live Cell Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies live cell imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the live cell imaging companies profiled in this report include-

  • Danaher
  • Zeiss
  • Nikon Corporation
  • Olympus Corporation
  • Perkinelmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • Cytosmart Technologies

Live Cell Imaging Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Within this market, stem cell will remain the largest segment due to its increasing adoption in cell replacement and tissue engineering therapies owing to their unique abilities to self-renew and differentiate into diverse cell types.

APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Features of the Global Live Cell Imaging Market

Market Size Estimates: Live cell imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Live cell imaging market by various segments, such as by product & service, technology, application, end use and region in terms of($B).

Regional Analysis: Live cell imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, technologies, applications, end uses, and regions for the live cell imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the live cell imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the live cell imaging market size?

Answer: The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030.

Q.2 What is the growth forecast for live cell imaging market?

Answer: The global live cell imaging market is expected to grow with a CAGR of 11.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the live cell imaging market?

Answer: The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

Q4. What are the major segments for live cell imaging market?

Answer: The future of the live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets.

Q5. Who are the key live cell imaging market companies?

Answer: Some of the key live cell imaging companies are as follows:

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies

Q6. Which live cell imaging market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Q7. In live cell imaging market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the live cell imaging market by product & service (instruments, consumables, software, services, and others), technology (time-lapse microscopy, fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high content screening, and others), application (cell biology, stem cells, developmental biology, drug discovery, and others), end use (pharmaceutical & biotechnology companies, academic and research institutes, contract research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Live Cell Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Live Cell Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Live Cell Imaging Market by Product & Service
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
    • 3.3.5: Others
  • 3.4: Global Live Cell Imaging Market by Technology
    • 3.4.1: Time-Lapse Microscopy
    • 3.4.2: Fluorescence Resonance Energy Transfer
    • 3.4.3: Fluorescence Recovery After Photobleaching
    • 3.4.4: High Content Screening
    • 3.4.5: Others
  • 3.5: Global Live Cell Imaging Market by Application
    • 3.5.1: Cell Biology
    • 3.5.2: Stem Cells
    • 3.5.3: Developmental Biology
    • 3.5.4: Drug Discovery
    • 3.5.5: Others
  • 3.6: Global Live Cell Imaging Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: Academic and Research Institutes
    • 3.6.3: Contract Research Organisations
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Live Cell Imaging Market by Region
  • 4.2: North American Live Cell Imaging Market
    • 4.2.2: North American Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.3: European Live Cell Imaging Market
    • 4.3.1: European Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.3.2: European Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.4: APAC Live Cell Imaging Market
    • 4.4.1: APAC Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.4.2: APAC Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.5: ROW Live Cell Imaging Market
    • 4.5.1: ROW Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.5.2: ROW Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Live Cell Imaging Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Live Cell Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Live Cell Imaging Market by Application
    • 6.1.4: Growth Opportunities for the Global Live Cell Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Live Cell Imaging Market by Region
  • 6.2: Emerging Trends in the Global Live Cell Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Live Cell Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Live Cell Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Danaher
  • 7.2: ZEISS
  • 7.3: Nikon Corporation
  • 7.4: Olympus Corporation
  • 7.5: PerkinElmer
  • 7.6: Sartorius
  • 7.7: Agilent Technologies
  • 7.8: Thermo Fisher Scientific
  • 7.9: Etaluma
  • 7.10: CytoSMART Technologies